{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pine Brook",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76664",
      "recalling_firm": "Alvogen, Inc",
      "address_1": "10 Bloomfield Ave Bldg B Ste 2",
      "address_2": "N/A",
      "postal_code": "07058-9743",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0631-2017",
      "product_description": "Nifedipine Extended-Release Tablets, 90 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-370-01.",
      "product_quantity": "N/A",
      "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib",
      "recall_initiation_date": "20170307",
      "center_classification_date": "20170404",
      "termination_date": "20171215",
      "report_date": "20170412",
      "code_info": "Lot #:  BXH1P51, BXH66D1, BXH1P51A, BXH5ZS1, Exp. 03/2018; BXH1P52, Exp. 05/2018; BXHBKF1A, and BXHB8S1A, Exp. 10/2018."
    }
  ]
}